The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta‐analysis of 2720 cases

Transfusion Medicine - Tập 25 Số 3 - Trang 151-162 - 2015
Zhenhong Wei1, M. Liu1
1Department of Trauma, Union Medicine Centre of Tianjin, Tianjin, China

Tóm tắt

SUMMARYAimsTo evaluate the safety and efficacy of tranexamic acid (TXA) in total knee arthroplasty (TKA) and total hip arthroplasty (THA). The specific endpoints assessed in this meta‐analysis include the total blood loss, the incidence rate of deep vein thrombosis (DVT) and pulmonary embolisms (PE), the number of patients requiring at least 1 U of red blood cell following surgery.BackgroundThe prevalence of THA and TKA is increasing and both are usually accompanied by considerable blood loss. TXA has been reported to reduce total blood loss in many orthopaedic surgeries. TXA administration continues to be a controversial topic in the literature about joint arthroplasty, and many studies have reported substantial doubt with respect to its benefits and safety.Methods/materialsWe conducted a meta‐analysis that combined all data from available randomised controlled trials, regardless the methods of TXA administration, which included administrated intravenously, intra‐articularly, topically or orally. Finally, available data from the 39 included trials were pooled for analysis. Then, mean differences with 95% confidence intervals (CIs) was calculated for continuous outcomes and relative risks with 95% CIs for dichotomous outcomes.ResultsThis meta‐analysis suggests that the administration of TXA significantly reduced blood loss and the need for allogeneic blood transfusion, without apparent increased risk of DVT or PE thromboembolic complications.ConclusionTo our knowledge, this meta‐analysis is more powerful and persuasive than any other published before. It suggests that the use of TXA reduced the risk of blood loss and the need for allogeneic blood transfusion significantly, without apparent increased risk of DVT or PE complications.

Từ khóa


Tài liệu tham khảo

10.1016/j.transci.2013.09.005

10.1111/j.1537-2995.2007.01564.x

10.1080/000164701753532754

10.1016/j.ejvs.2008.12.002

10.1093/bja/ael057

10.1007/s11999-011-1874-2

10.1080/00015458.2007.11680081

10.1016/j.otsr.2011.12.005

10.1016/j.arth.2013.09.002

10.4103/0019-5413.77135

10.1213/00000539-200011000-00014

10.1016/S0952-8180(01)00319-1

10.1186/1756-0500-6-184

10.1016/j.arth.2003.12.073

10.1016/j.jcot.2013.01.007

10.1016/j.arth.2013.03.038

10.1093/bja/aeg111

10.1371/journal.pone.0055073

HigginsJPT GreenS(2011)Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. URLhttp://www.cochrane‐handbook.org(Accessed 30/12/12).

10.1213/00000539-199704000-00026

10.1016/j.arth.2014.05.026

10.1080/00016470310018171

10.1007/s004029900132

10.1016/j.arth.2012.04.024

10.1007/s00264-010-1205-3

10.1080/00016470510030751

10.1016/j.thromres.2008.09.015

Kakar P.N., 2009, Efficacy and safety of Tranexamic acid in control of bleeding following TKR: a randomized clinical trial, Indian Journal of Anesthesia, 53, 667

10.3928/01477447-20091124-30

10.1016/j.arth.2013.06.011

Kruithof E.K., 1987, Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation, Blood, 70, 1645, 10.1182/blood.V70.5.1645.1645

10.1007/BF03018543

10.1016/j.arth.2009.11.013

10.1007/s00590-010-0671-z

10.1016/j.arth.2013.10.005

10.1016/j.knee.2011.06.004

10.1302/0301-620X.89B3.17565

10.1080/17453670510045444

10.1111/trf.12224

10.1016/j.knee.2005.11.001

10.1007/BF03022249

10.1016/j.knee.2013.05.014

10.1007/s11999-009-1217-8

10.1007/s00590-011-0845-3

10.1016/j.tracli.2008.09.024

10.1007/s00167-012-1942-5

10.1302/0301-620X.93B1.24984

10.1016/j.jss.2013.03.099

10.1302/0301-620X.83B5.11745

10.1053/j.seminhematol.2003.11.025

10.1034/j.1399-6576.2002.461007.x

10.2106/JBJS.I.01518

10.1007/s00264-003-0511-4

10.2106/JBJS.D.02046

10.1007/s00402-013-1761-2

10.1213/01.ANE.0000136770.75805.19

Thông tin
Thông tin xuất bản

Transfusion Medicine

Tập 25 Số 3

151-162

Thông tin tác giả